Every person facing cancer deserves access to clear information, personalized treatment, and meaningful support. But for many people in historically marginalized communities, that isn’t always the reality.
Research shows that Black patients are more comfortable working with providers of the same race, yet only about 3% of oncologists in the U.S. are Black (Scientific American, 2021). This lack of representation can lead to less participation in conversations during appointments and may contribute to delays in diagnosis, missed referrals, and lower overall satisfaction with care.
Providers themselves acknowledge this gap. Many report that care for African American patients could be improved through greater cultural sensitivity, stronger education and training, and more diverse care teams (Smith et al., 2008). The need is especially urgent when it comes to critical topics like end-of-life care, genetic testing, and treatment planning—where disparities can have lasting consequences.
When the Data Doesn’t Reflect Everyone
Most treatment guidelines and survival estimates in cancer care are based on clinical trials and population statistics from sources like the National Cancer Institute and American Cancer Society. But here’s the problem: ethnic and racial minorities are often underrepresented in those trials, even though these same groups experience higher cancer mortality rates than the general population (Scientific American, 2021).
When the data isn’t diverse, the care can’t be either. It limits the scientific quality of research, makes results less generalizable, and slows innovation. It also means that people of color often receive care based on averages that don’t reflect their lived experience, health history, or community context.
How Ardynn Is Changing the Story
At Ardynn, we believe every person deserves care that reflects their full story—not just their diagnosis.
That’s why we draw on one of the largest real-world cancer outcomes datasets available—millions of patients, including those often excluded from clinical trials, such as people with diabetes, heart disease, or limited access to specialty care. This allows us to offer personalized insights grounded in real-world outcomes, not just trial averages.
We also understand the importance of human connection. When possible, we match members with board-certified advocates who reflect their background or lived experience—to share knowledge, offer support, and help build trust in the care process.
Because when people are seen, heard, and supported, they’re more likely to ask questions, explore their options, and advocate for what matters most. That can mean earlier referrals for genetic testing, more awareness of treatment side effects, or better understanding of palliative and supportive care options.
Awareness Is the First Step
The first step is having the right information. The second is seeing how it applies to you.
At Ardynn, we help people understand their treatment choices in the context of their personal values, health conditions, and goals for care. We’re here to answer questions, explain options, and provide a safe space to explore next steps.
If you or someone you care about is navigating a cancer diagnosis, you’re not alone. To get started with an advocate, contact Ardynn member services at 737-307-0077 or click here to schedule an introductory call.
Because representation matters. Personalization matters. And you matter.
